Prions and their lethal journey to the brain - Nature Reviews Microbiology
- ️MacPherson, G. Gordon
- ️Mon Feb 06 2006
Will, R. G., Alpers, M. P., Dormont, D. & Schonberger, L. B. Infectious and sporadic prion diseases. In Prion Biology and Diseases (ed. Prusiner, S. B.) 629–693 (Cold Spring Harbor Laboratory Press, New York, 2004).
Hill, A. F. & Collinge, J. Subclinical prion infection. Trends Microbiol. 11, 578–584 (2003).
Peden, A. H., Head, M. W., Ritchie, D. L., Bell, J. E. & Ironside, J. W. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 354, 527–529 (2004).
Castilla, J., Saá, P. & Soto, C. Detection of prions in blood. Nature Med. 11, 982–985 (2005). Describes the development of technology that might allow the early diagnosis of TSE diseases from blood samples.
Büeler, H. et al. Mice devoid of PrP are resistant to scrapie. Cell 73, 1339–1347 (1993).
Bolton, D. C., McKinley, M. P. & Prusiner, S. B. Identification of a protein that purifies with the scrapie prion. Science 218, 1309–1311 (1982). Describes the discovery of PrPSc from a hamster infected with scrapie.
Prusiner, S. B. et al. Further purification and characterisation of scrapie prions. Biochemistry 21, 6942–6950 (1982).
Legname, G. et al. Synthetic mammalian prions. Science 305, 673–676 (2004).
van Keulen, L. J. M. et al. Immunohistological detection of prion protein in lymphoid tissues of sheep with natural scrapie. J. Clin. Microbiol. 34, 1228–1231 (1996). Shows that, when polymerized into β-sheet-rich amyloid fibrils (synthetic prions), recombinant mouse PrP can transmit disease when injected into transgenic mice.
Sigurdson, C. J. et al. Oral transmission and early lymphoid tropism of chronic wasting disease PrPres in mule deer fawns (Odocoileus hemionus). J. Gen. Virol. 80, 2757–2764 (1999).
Hadlow, W. J., Race, R. E. & Kennedy, R. C. Temporal distribution of transmissible mink encephalopathy virus in mink inoculated subcutaneously. J. Virol. 61, 3235–3240 (1987).
Hilton, D., Fathers, E., Edwards, P., Ironside, J. & Zajicek, J. Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt–Jakob disease. Lancet 352, 703–704 (1998).
Terry, L. A. et al. Detection of disease-specific PrP in the distal ileum of cattle exposed orally to the agent of bovine spongiform encephalopathy. Vet. Rec. 152, 387–392 (2003).
Wadsworth, J. D. F. et al. Tissue distribution of protease resistant prion protein in variant Creutzfeldt–Jakob disease using a highly sensitive immunoblotting assay. Lancet 358, 171–180 (2001).
Foster, J. D., Parnham, D. W., Hunter, N. & Bruce, M. Distribution of the prion protein in sheep terminally affected with BSE following experimental oral transmission. J. Gen. Virol. 82, 2319–2326 (2001).
Glatzel, M., Abela, E., Maissen, M. & Aguzzi, A. Extraneural pathological prion protein in sporadic Creutzfeldt–Jakob disease. New Engl. J. Med. 349, 1812–1820 (2003).
Jeffrey, M. et al. Occurrence and distribution of infection-specific PrP in tissues of clinical scrapie cases and cull sheep from scrapie-affected farms in Shetland. J. Comp. Pathol. 127, 264–273 (2002).
Benestad, S. L. et al. Cases of scrapie with unusual features in Norway and designation of new type, Nor98. Vet. Rec. 153, 202–208 (2003).
Mabbott, N. A., Young, J., McConnell, I. & Bruce, M. E. Follicular dendritic cell dedifferentiation by treatment with an inhibitor of the lymphotoxin pathway dramatically reduces scrapie susceptibility. J. Virol. 77, 6845–6854 (2003).
Prinz, M. et al. Oral prion infection requires normal numbers of Peyer's patches but not of enteric lymphocytes. Am. J. Pathol. 162, 1103–1111 (2003).
Fraser, H. & Dickinson, A. G. Pathogenesis of scrapie in the mouse: the role of the spleen. Nature 226, 462–463 (1970).
Mohan, J., Bruce, M. E. & Mabbott, N. A. Follicular dendritic cell dedifferentiation reduces scrapie susceptibility following inoculation via the skin. Immunology 114, 225–234 (2005).
Kitamoto, T., Muramoto, T., Mohri, S., Doh-Ura, K. & Tateishi, J. Abnormal isoform of prion protein accumulates in follicular dendritic cells in mice with Creutzfeldt–Jakob disease. J. Virol. 65, 6292–6295 (1991).
Hill, A. F. et al. Investigation of variant Creutzfeldt–Jakob disease and other prion diseases with tonsil biopsy samples. Lancet 353, 183–189 (1999).
Sigurdson, C. J. et al. PrPCWD lymphoid cell targets in early and advanced chronic wasting disease of mule deer. J. Gen. Virol. 83, 2617–2628 (2002).
Mabbott, N. A. et al. Tumor necrosis factor-α-deficient, but not interleukin-6-deficient, mice resist peripheral infection with scrapie. J. Virol. 74, 3338–3344 (2000).
Jeffrey, M., McGovern, G., Goodsir, C. M., Brown, K. L. & Bruce, M. E. Sites of prion protein accumulation in scrapie-infected mouse spleen revealed by immuno-electron microscopy. J. Pathol. 191, 323–332 (2000).
Mabbott, N. A., Mackay, F., Minns, F. & Bruce, M. E. Temporary inactivation of follicular dendritic cells delays neuroinvasion of scrapie. Nature Med. 6, 719–720 (2000).
Montrasio, F. et al. Impaired prion replication in spleens of mice lacking functional follicular dendritic cells. Science 288, 1257–1259 (2000). References 28 and 29 show that depletion of FDCs blocks TSE agent accumulation in the spleen following intraperitoneal inoculation and delays neuroinvasion.
Mohan, J., Bruce, M. E. & Mabbott, N. A. Neuroinvasion by scrapie following inoculation via the skin is independent of migratory Langerhans cells. J. Virol. 79, 1888–1897 (2005).
Mackay, F. & Browning, J. L. Turning off follicular dendritic cells. Nature 395, 26–27 (1998).
Klein, M. A. et al. A crucial role for B cells in neuroinvasive scrapie. Nature 390, 687–691 (1997).
Prinz, M. et al. Lymph nodal prion replication and neuroinvasion in mice devoid of follicular dendritic cells. Proc. Natl Acad. Sci. USA 99, 919–924 (2002).
Mabbott, N. A., McGovern, G., Jeffrey, M. & Bruce, M. E. Temporary blockade of the tumour necrosis factor signaling pathway impedes the spread of scrapie to the brain. J. Virol. 76, 5131–5139 (2002).
Aguzzi, A. & Sigurdson, C. J. Antiprion immunotherapy: to suppress or to stimulate? Nature Rev. Immunol. 4, 725–736 (2004).
Brown, K. L. et al. Scrapie replication in lymphoid tissues depends on PrP-expressing follicular dendritic cells. Nature Med. 5, 1308–1312 (1999).
Manson, J. C., Clarke, A. R., McBride, P. A., McConnell, I. & Hope, J. PrP gene dosage determines the timing but not the final intensity or distribution of lesions in scrapie pathology. Neurodegeneration 3, 331–340 (1994).
Barclay, G. R., Houston, E. F., Halliday, S. I., Farquhar, C. F. & Turner, M. L. Comparative analysis of normal prion protein expression on human, rodent, and ruminant blood cells by using a panel of prion antibodies. Transfusion 42, 517–526 (2002).
Klein, M. A. et al. PrP expression in B lymphocytes is not required for prion neuroinvasion. Nature Med. 4, 1429–1433 (1998).
Mohan, J., Brown, K. L., Farquhar, C. F., Bruce, M. E. & Mabbott, N. A. Scrapie transmission following exposure through the skin is dependent on follicular dendritic cells in lymphoid tissues. J. Dermatol. Sci. 35, 101–111 (2004).
Montrasio, F. et al. B-lymphocyte-restricted expression of the prion protein does not enable prion replication in PrP knockout mice. Proc. Natl Acad. Sci. USA 98, 4034–4037 (2001).
Raeber, A. J. et al. Ectopic expression of prion protein (PrP) in T lymphocytes or hepatocytes of PrP knockout mice is insufficient to sustain prion replication. Proc. Natl Acad. Sci. USA 96, 3987–3992 (1999).
Lötscher, M., Recher, M., Hunzinker, L. & Klein, M. A. Immunologically induced, complement-dependent up-regulation of the prion protein in the mouse spleen: follicular dendritic cells versus capsule and trabeculae. J. Immunol. 170, 6040–6047 (2003).
van den Berg, T. K., Yoshida, K. & Dijkstra, C. D. Mechanisms of immune complex trapping by follicular dendritic cells. Curr. Top. Microbiol. Immunol. 201, 49–63 (1995).
Klein, M. A. et al. Complement facilitates early prion pathogenesis. Nature Med. 7, 488–492 (2001).
Mabbott, N. A., Bruce, M. E., Botto, M., Walport, M. J. & Pepys, M. B. Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie. Nature Med. 7, 485–487 (2001). References 45 and 46 show that complement components contribute to the early localization of TSE agents to the lymphoid tissues.
Blanquet-Grossard, F., Thielens, N. M., Vendrely, C., Jamin, M. & Arlaud, G. J. Complement protein C1q recognizes a conformationally modified form of the prion protein. Biochemistry 44, 4349–4356 (2005).
Mabbott, N. A. The complement system in prion diseases. Curr. Opin. Immunol. 16, 587–593 (2004).
Schwaeble, W. et al. Follicular dendritic cells, interdigitating cells, and cells of the monocyte-macrophage lineage are the C1q-producing sources in the spleen. J. Immunol. 155, 4971–4978 (1995).
McGovern, G., Brown, K. L., Bruce, M. E. & Jeffrey, M. Murine scrapie infection causes an abnormal germinal centre reaction in the spleen. J. Comp. Pathol. 130, 181–194 (2004).
Blättler, T. et al. PrP-expressing tissue required for transfer of scrapie infectivity from spleen to brain. Nature 389, 69–73 (1997).
Kaeser, P. S., Klein, M. A., Schwarz, P. & Aguzzi, A. Efficient lymphoreticular prion propagation requires PrPc in stromal and hematopoietic cells. J. Virol. 75, 7097–7106 (2001).
Bartz, J. C., DeJoia, C., Tucker, T., Kincaid, A. E. & Bessen, R. A. Extraneural prion neuroinvasion without lymphoreticular system infection. J. Virol. 79, 11858–11863 (2005).
Neutra, M. R., Frey, A. & Kraehenbuhl, J. -P. Epithelial M cells: gateways for mucosal infection and immunization. Cell 86, 345–348 (1996).
Heppner, F. L. et al. Transepithelial prion transport by M cells. Nature Med. 7, 976–977 (2001). Shows that M cells have the potential to transport TSE agents across the intestinal epithelium.
Mishra, R. S. et al. Protease-resistant human prion protein and ferritin are cotransported across Caco-2 epithelial cells: Implications for species barrier in prion uptake from the intestine. J. Neurosci. 24, 11280–11290 (2004). Shows that intestinal epithelial cells can translocate PrPSc in a ferritin-dependent manner.
Beekes, M. & McBride, P. A. Early accumulation of pathological PrP in the enteric nervous system and gut-associated lymphoid tissue of hamsters orally infected with scrapie. Neurosci. Lett. 278, 181–184 (2000).
Herrmann, L. M., Cheevers, W. P., Davis, W. C., Knowles, D. P. & O'Rourke, K. I. CD21-positive follicular dendritic cells: a possible source of PrPSc in lymph node macrophages of scrapie-infected sheep. Am. J. Pathol. 162, 1075–1081 (2003).
Carp, R. I. & Callahan, S. M. In vitro interaction of scrapie agent and mouse peritoneal macrophages. Intervirology 16, 8–13 (1981).
Carp, R. I. & Callahan, S. M. Effect of mouse peritoneal macrophages on scrapie infectivity during extended in vitro incubation. Intervirology 17, 201–207 (1982).
Maignien, T. et al. Role of gut macrophages in mice orally contaminated with scrapie or BSE. Int. J. Pharm. 298, 293–304 (2005).
Beringue, V. et al. Role of spleen macrophages in the clearance of scrapie agent early in pathogenesis. J. Pathol. 190, 495–502 (2000).
Cunningham, C., Wilcockson, D. C., Boche, D. & Perry, V. H. Comparison of inflammatory and acute-phase responses in the brain and peripheral organs of the ME7 model of prion disease. J. Virol. 79, 5174–5184 (2005).
Prinz, M. et al. Prion pathogenesis in the absence of Toll-like receptor signalling. EMBO Rep. 4, 195–199 (2003).
Huang, F. -P., Farquhar, C. F., Mabbott, N. A., Bruce, M. E. & MacPherson, G. G. Migrating intestinal dendritic cells transport PrPSc from the gut. J. Gen. Virol. 83, 267–271 (2002). Shows that a subpopulation of migratory DCs can acquire disease-specific PrP from the intestine.
Endres, R. et al. Mature follicular dendritic cell networks depend on expression of lymphotoxin β receptor by radioresistant stromal cells and of lymphotoxin β and tumour necrosis factor by B cells. J. Exp. Med. 189, 159–168 (1999).
Kapasi, Z. F., Burton, G. F., Schultz, L. D., Tew, J. G. & Szakal, A. K. Induction of functional follicular dendritic cell development in severe combined immunodeficiency mice. J. Immunol. 150, 2648–2658 (1993).
Shortman, K. & Liu, Y. -J. Mouse and human dendritic cell subtypes. Nature Rev. Immunol. 2, 151–161 (2002).
Liu, M. & MacPherson, G. G. Antigen acquisition by dendritic cells: intestinal dendritic cells acquire antigen administered orally and can prime naive T cells in vivo. J. Exp. Med. 177, 1299–1307 (1993).
Rescigno, M. et al. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nature Immunol. 2, 361–367 (2001).
Banchereau, J. et al. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767–811 (2000).
Luhr, K. M. et al. Processing and degradation of exogenous prion protein by CD11c+ myeloid dendritic cells in vitro. J. Virol. 76, 12259–12264 (2002).
Mohan, J., Hopkins, J. & Mabbott, N. A. Skin-derived dendritic cells acquire and degrade the scrapie agent following in vitro exposure. Immunology 116, 122–133 (2005).
Luhr, K. M. et al. Scrapie protein degradation by cysteine proteases in CD11c+ dendritic cells and GT1-neuronal cells. J. Virol. 78, 4776–4782 (2004).
Wykes, M., Pombo, A., Jenkins, C. & MacPherson, G. G. Dendritic cells interact directly with naive B lymphocytes to transfer antigen and initiate class switching in a primary T-dependent response. J. Immunol. 161, 1313–1319 (1998).
Huang, F. -P. et al. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes. J. Exp. Med. 191, 435–443 (2000).
Kaneider, N. C., Kaser, A., Dunzendorfer, S., Tilg, H. & Wiedermann, C. J. Sphingosine kinase-dependent migration of immature dendritic cells in response to neurotoxic prion protein fragment. J. Virol. 77, 5535–5539 (2003).
Kaneider, N. C. et al. Neurokinin-1 receptor interacts with PrP106–126-induced dendritic cell migration and interaction. J. Neuroimmunol. 158, 153–158 (2005).
Pugh, C. W., MacPherson, G. G. & Steer, H. W. Characterization of non-lymphoid cells derived from rat peripheral lymph. J. Exp. Med. 157, 1758–1779 (1983).
Liu, L., Zhang, M., Jenkins, C. & MacPherson, G. G. Dendritic cell heterogeneity in vivo: two functionally different dendritic cell populations in rat intestinal lymph can be distinguished by CD4 expression. J. Immunol. 161, 1146–1155 (1998).
Oldstone, M. B. A. et al. Lymphotoxin-α- and lymphotoxin-β-deficient mice differ in susceptibility to scrapie: evidence against dendritic cell involvement. J. Virol. 76, 4357–4363 (2002).
Fraser, H. et al. Replication of scrapie in spleens of SCID mice follows reconstitution with wild-type mouse bone marrow. J. Gen. Virol. 77, 1935–1940 (1996).
Berney, C. et al. A member of the dendritic cell family that enters B cell follicles and stimulates primary antibody responses identified by a mannose receptor fusion protein. J. Exp. Med. 190, 851–860 (1999).
Yu, P. et al. B cells control the migration of a subset of dendritic cells into B cell follicles via CXC chemokine ligand 13 in a lymphotoxin-dependent fashion. J. Immunol. 168, 5117–5123 (2002).
Denzer, K., Kleijmeer, M. J., Heijnen, H. F. G., Stoorvogel, W. & Geuze, H. J. Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J. Cell Sci. 113, 3365–3374 (2000).
Fevrier, B. et al. Cells release prions in association with exosomes. Proc. Natl Acad. Sci. USA 101, 9683–9688 (2004). Shows that PrPSc released from infected cells by exosomes is infectious.
Théry, C., Zitvogel, L. & Amigorena, S. Exosomes: composition, biogenesis and function. Nature Rev. Immunol. 2, 569–579 (2002).
Denzer, K. et al. Follicular dendritic cells carry MHC class II-expressing microvesicles at their surface. J. Immunol. 165, 1259–1265 (2000).
Gould, S. J., Booth, A. M. & Hildreth, J. E. K. The trojan exosome hypothesis. Proc. Natl Acad. Sci. USA 100, 10592–10597 (2003).
Nguyen, D. G., Booth, A., Gould, S. J. & Hildreth, J. E. Evidence that HIV budding in primary macrophages occurs through the exosome release pathway. J. Biol. Chem. 278, 52347–52354 (2003).
Beekes, M., Baldauf, E. & Diringer, H. Sequential appearance and accumulation of pathognomonic markers in the central nervous system of hamsters orally infected with scrapie. J. Gen. Virol. 77, 1925–1934 (1996).
Baldauf, E., Beekes, M. & Diringer, H. Evidence for an alternative direct route of access for the scrapie agent to the brain bypassing the spinal cord. J. Gen. Virol. 78, 1187–1197 (1997).
Beekes, M., McBride, P. A. & Baldauf, E. Cerebral targeting indicates vagal spread of infection in hamsters fed with scrapie. J. Gen. Virol. 79, 601–607 (1998).
McBride, P. A. & Beekes, M. Pathological PrP is abundant in sympathetic and sensory ganglia of hamsters fed with scrapie. Neurosci. Lett. 265, 135–138 (1999).
McBride, P. A. et al. Early spread of scrapie from the gastrointestinal tract to the central nervous system involves autonomic fibers of the splanchnic and vagus nerves. J. Virol. 75, 9320–9327 (2001). Detailed analysis of the early spread of disease-specific PrP through the peripheral nervous system in orally inoculated rodents.
Heggebø, R. et al. Disease associated PrP in the enteric nervous system of scrapie-affected sheep. J. Gen. Virol. 84, 1327–1338 (2003).
van Keulen, L. J., Schreuder, B. E., Vromans, M. E., Langeveld, J. P. & Smits, M. A. Pathogenesis of natural scrapie in sheep. Arch. Virol. Suppl. 16, 57–71 (2000).
Sigurdson, C. J., Spraker, T. R., Miller, M. W., Oesch, B. & Hoover, E. A. PrPCWD in the myenteric plexus, vagosympathetic trunk and endocrine glands of deer with chronic wasting disease. J. Gen. Virol. 82, 2327–2334 (2001).
Haïk, S. et al. The sympathetic nervous system is involved in variant Creutzfeldt–Jakob disease. Nature Med. 9, 1121–1123 (2003).
Glatzel, M., Heppner, F. L., Albers, K. M. & Aguzzi, A. Sympathetic innervation of lymphoreticular organs is rate limiting for prion neuroinvasion. Neuron 31, 25–34 (2001). Shows that depletion of sympathetic nerves prevents TSE agent neuroinvasion following peripheral inoculation.
Glatzel, M. & Aguzzi, A. PrPc expression in the peripheral nervous system is a determinant of prion neuroinvasion. J. Gen. Virol. 81, 2813–2821 (2000).
Race, R., Oldstone, M. & Chesebro, B. Entry versus blockade of brain infection following oral or intraperitoneal scrapie administration: role of prion protein expression in peripheral nerves and spleen. J. Gen. Virol. 74, 828–833 (2000).
Felten, S. Y. & Felten, D. L. Innervation of lymphoid tissue. In Psychoneuroimmunology (eds Ader, R., Felten, D. & Cohen, N.) 27–69 (Academic Press Inc., San Diego, 1991). Detailed illustrated description of the innervation of lymphoid tissues.
Defaweux, V. et al. Interfaces between dendritic cells, other immune cells, and nerve fibres in mouse Peyer's patches: potential sites for neuroinvasion in prion diseases. Microsc. Res. Tech. 66, 1–9 (2005).
Hosoi, J. et al. Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature 363, 159–163 (1993).
Aucouturier, P. et al. Infected splenic dendritic cells are sufficient for prion transmission to the CNS in mouse scrapie. J. Clin. Invest. 108, 703–708 (2001).
Prinz, M. et al. Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion. Nature 425, 957–962 (2003). Shows that the rate of TSE agent neuroinvasion from the spleen is proportional to the distance between FDCs and sympathetic nerves.
Brown, P. The risk of blood-borne Creutzfeldt–Jakob disease. In Transmissible Subacute Spongiform Encephalopathies: Prion Diseases (eds. Court, L. & Dodet, B.) 447–450 (Elsevier, Paris, 1996).
Llewelyn, C. A. et al. Possible transmission of variant Creutzfeldt–Jakob disease by blood transfusion. Lancet 363, 417–421 (2004).
Hunter, N. et al. Transmission of prion diseases by blood transfusion. J. Gen. Virol. 83, 2897–2905 (2002). Shows that TSE agent transmission can occur by blood transmission from a pre-clinical donor.
Brown, P. et al. The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy. Transfusion 38, 810–816 (1998).
Rosicarelli, B. et al. Migration of dendritic cells into the brain in a mouse model of prion disease. J. Neuroimmunol. 165, 114–120 (2005).
Lewicki, H. et al. T cells infiltrate the brain in murine and human transmissible spongiform encephalopathies. J. Virol. 77, 3799–3808 (2003).
Armstrong, R. A., Cairns, N. J., Ironside, J. W. & Lantos, P. L. Does the neuropathology of human patients with variant Creutzfeldt–Jakob disease reflect haematogenous spread of the disease? Neurosci. Lett. 348, 37–40 (2003).
Burton, G. F., Brandon, F. K., Estes, J. D., Thacker, T. C. & Gartner, S. Follicular dendritic cell contributions to HIV pathogenesis. Sem. Immunol. 14, 275–284 (2002).
Banki, Z. et al. Complement dependent trapping of infectious HIV in human lymphoid tissues. AIDS 19, 481–486 (2005).
Wadsworth, J. D. F. et al. Human prion protein with valine 129 prevents expression of variant CJD phenotype. Science 306, 1793–1796 (2004).
Goldmann, W., Hunter, N., Smith, G., Foster, J. & Hope, J. PrP genotype and agent effects in scrapie: change in allelic interaction with different isolates of agent in sheep, a natural host of scrapie. J. Gen. Virol. 75, 989–995 (1994). Shows that the PRNP genotype can affect susceptibility to scrapie in sheep.
Thackray, A. M., McKenzie, A. N., Klein, M. A., Lauder, A. & Bujdoso, R. Accelerated prion disease in the absence of interleukin-10. J. Virol. 78, 13697–13707 (2004). Shows that intestinal inflammation can dramatically affect TSE disease pathogenesis.
Heikenwalder, M. et al. Chronic lymphocytic inflammation specifies the organ tropism of prions. Science 307, 1107–1110 (2005).
Seeger, H. et al. Coincident scrapie infection and nephritis lead to urinary prion excretion. Science 310, 324–326 (2005).
Ligios, C. et al. PrPSc in mammary glands of sheep affected by scrapie and mastitis. Nature Med. 11, 1137–1138 (2005). Shows that natural chronic inflammatory conditions and coincident natural scrapie can expand the deposition of PrPSc within sheep tissues.
Stahl, N., Borchelt, D. R., Hsiao, K. & Prusiner, S. B. Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 51, 229–240 (1987).
Pan, K. -M. et al. Conversion of α-helices into β-sheets features in the formation of the scrapie prion protein. Proc. Natl Acad. Sci. USA 90, 10962–10966 (1993).
Riek, R., Hornemann, S., Wider, G., Glockshuber, R. & Wuthrich, K. NMR characterization of the full-length recombinant murine prion protein, mPrP(23–231). FEBS Lett. 413, 282–288 (1997).
Tobler, I. et al. Altered circadian activity rythyms and sleep in mice devoid of prion protein. Nature 380, 639–642 (1996).
Bueler, H. et al. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356, 577–582 (1992).
Caughey, B. W. et al. Secondary structure analysis of the scrapie-associated protein PrP 27–30 in water by infrared spectroscopy. Biochemistry 30, 7672–7680 (1991).
Safar, J. G. et al. Search for prion-specific nucleic acid. J. Virol. 79, 10796–10806 (2005).
Prusiner, S. B. Novel proteinaceous infectious particles cause scrapie. Science 216, 136–144 (1982). An important milestone in TSE disease research. Description of the 'prion' hypothesis.
Silveira, J. R. et al. The most infectious prion particles. Nature 437, 257–261 (2005). Shows that non-fibrillar particles, comprising approximately 14–28 PrP molecules, are the most efficient initiators of TSE disease.
Imazeki, N., Senoo, A. & Fuse, Y. Is the follicular dendritic cell a primarily stationary cell? Immunology 76, 508–510 (1992).
Mandel, T. E., Phipps, R. P., Abbot, A. & Tew, J. G. The follicular dendritic cell: long term antigen retention during immunity. Immunol. Rev. 53, 29–59 (1980).
Yoshida, K., van den Berg, T. K. & Dijkstra, C. D. Two functionally different follicular dendritic cells in secondary lymphoid follicles of mouse spleen, as revealed by CR1/2 and FcRγII-mediated immune-complex trapping. Immunology 80, 34–39 (1993).
Kosco-Vilbois, M. H. Are follicular dendritic cells really good for nothing? Nature Rev. Immunol. 3, 764–769 (2003).
Haberman, A. M. & Shlomchik, M. J. Reassessing the function of immune-complex retention by follicular dendritic cells. Nature Rev. Immunol. 3, 757–764 (2003).